Ileana Quinto
Catanzaro, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma.
Journal: Communications biology
Published: March 05, 2024
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.
Journal: Frontiers in oncology
Published: November 17, 2023
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype.
Journal: Cells
Published: February 17, 2023
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections.
Journal: Clinical chemistry and laboratory medicine
Published: October 26, 2022
A novel phage display based platform for exosome diversity characterization.
Journal: Nanoscale
Published: February 10, 2022
IBtkα Activates the β-Catenin-Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3β in Cancerous B Cells.
Journal: International journal of molecular sciences
Published: January 10, 2022
Metabolites Profiling of Melanoma Interstitial Fluids Reveals Uridine Diphosphate as Potent Immune Modulator Capable of Limiting Tumor Growth.
Journal: Frontiers in cell and developmental biology
Published: June 25, 2021
Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy.
Journal: Viruses
Published: March 12, 2021
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 06, 2020
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 18, 2020
Last Updated: 09/26/2026